Harvey, KenLokuge, BuddhimaDrahos, PeterFaunce, Thomas2015-12-132015-12-130025-729Xhttp://hdl.handle.net/1885/87514• The Australia-United States Free Trade Agreement (AUSFTA) contains major concessions to the US pharmaceutical industry that may undermine the egalitarian principles and operation of the Pharmaceutical Benefits Scheme (PBS) and substantially increase t© Copyright 2004. The Medical Journal of Australia –reproduced with permission.Keywords: generic drug; article; Australia; consumer; cost effectiveness analysis; drug cost; drug industry; drug manufacture; health care access; health care cost; health care policy; health insurance; law; patent; public health; reward; United States; Australia;20042015-12-12